|
Clevidipine
|
|
167221-71-8
|
|
Bradykinin (1-7)
|
|
23815-87-4
|
|
MK-5046
|
|
1022152-70-0
|
|
RN486
|
|
1242156-23-5
|
|
Spebrutinib
|
|
1202757-89-8
|
|
XL228
|
|
898280-07-4
|
|
Tirabrutinib
|
|
1351636-18-4
|
|
Orelabrutinib
|
|
1655504-04-3
|
|
ML230
|
|
1776055-05-0
|
|
BV02
|
|
292870-53-2
|
|
NS-638
|
|
150493-34-8
|
|
TTA-Q6
|
|
910484-28-5
|
|
PCI 29732
|
|
330786-25-9
|
|
Omaveloxolone
|
|
1474034-05-3
|
|
HUP30
|
|
312747-21-0
|
|
Ibrutinib-biotin
|
|
1599432-18-4
|
|
Neuromedin B (porcine)
|
|
87096-84-2
|
|
Fantofarone
|
|
114432-13-2
|
|
Acalabrutinib
|
|
1420477-60-6
|
|
Mirogabalin
|
|
1138245-13-2
|
|
YHO-13351 free base
|
|
912288-64-3
|
|
Asciminib
|
|
1492952-76-7
|
|
BMS-935177
|
|
1231889-53-4
|
|
LXH254
|
|
1800398-38-2
|
|
BTK inhibitor 10
|
|
2241732-30-7
|
|
TAK-020
|
|
1627603-21-7
|
|
Ponatinib-d8
|
|
1562993-37-6
|
|
PTC209 HBr
|
|
1217022-63-3
|
|
Ca2+ channel agonist 1
|
|
1402821-24-2
|
|
Fenebrutinib
|
|
1434048-34-6
|
|
BMS-986142
|
|
1643368-58-4
|
|
ACT-709478
|
|
1838651-58-3
|
|
Pirtobrutinib
|
|
2101700-15-4
|
|
Ac32Az19
|
|
2760674-72-2
|
|
GNF-5
|
|
778277-15-9
|
|
Acetylcholine-d4 (chloride)
|
|
344298-94-8
|
|
GV-58
|
|
1402821-41-3
|
|
Nilotinib-d6
|
|
1268356-17-7
|
|
Btk inhibitor 2
|
|
1558036-85-3
|
|
Des-Arg9]-Bradykinin acetate
|
|
23827-91-0
|
|
ARQ 531
|
|
2095393-15-8
|
|
Pinaverium bromide
|
|
53251-94-8
|
|
BIIB068
|
|
1798787-27-5
|
|
Pranidipine
|
|
99522-79-9
|
|
Rebastinib
|
|
1020172-07-9
|
|
(±)-Zanubrutinib
|
|
1633350-06-7
|
|
Verapamil
|
|
52-53-9
|
|
Cinacalcet
|
|
226256-56-0
|
|
GMB-475
|
|
2490599-18-1
|
|
(Rac)-MEM 1003
|
|
165187-25-7
|
|
(S)-Sunvozertinib
|
|
2370013-49-1
|
|
trans-Ned 19
|
|
1354235-96-3
|
|
Sunvozertinib
|
|
2370013-12-8
|
|
Cinacalcet HCl
|
|
364782-34-3
|
|
Ulixacaltamide
|
|
1199236-64-0
|
|
Mirogabalin besylate
|
|
1138245-21-2
|
|
GSK-7975A
|
|
1253186-56-9
|
|
Cav 2.2 blocker 1
|
|
1567335-29-8
|
|
SJF620
|
|
2376187-16-3
|
|
(R)-Pirtobrutinib
|
|
2101700-14-3
|
|
Lys-[Des-Arg9]Bradykinin TFA
|
|
2763588-90-3
|
|
Nicardipine-d3 (hydrochloride)
|
|
1432061-50-1
|
|
Etiracetam
|
|
33996-58-6
|
|
Suvecaltamide
|
|
953778-58-0
|
|
DPH
|
|
484049-04-9
|
|
SB 290157 (trifluoroacetate salt)
|
|
1140525-25-2
|
|
Olverembatinib
|
|
1257628-77-5
|
|
Olverembatinib dimesylate
|
|
1421783-64-3
|
|
Dihydrodiol-Ibrutinib
|
|
1654820-87-7
|
|
BDP TMR NHS ester
|
BODIPYTMRNHS活化酯
|
485397-12-4
|
|
BODIPYFLcarboxylicacid
|
BODIPYFL羧酸
|
165599-63-3
|
|
BODIPY564/570carboxylicacid
|
BODIPY564/570羧酸
|
150173-89-0
|
|
Drotaverine hydrochloride
|
|
985-12-6
|
|
Bafetinib
|
|
859212-16-1
|
|
Carboxyamidotriazole Orotate
|
|
187739-60-2
|
|
BODIPYFLNHSester
|
BODIPYFLNHS活化酯
|
146616-66-2
|
|
ONO-4059 analog
|
|
1351635-67-0
|
|
Tirabrutinib hydrochloride
|
|
1439901-97-9
|
|
Zanubrutinib
|
|
1691249-45-2
|
|
(S)-ML753286
|
|
1699720-85-8
|
|
TTA-Q6(isomer)
|
|
910484-32-1
|
|
Asciminib hydrochloride
|
|
2119669-71-3
|
|
BIIB091
|
|
2247614-80-6
|
|
Elacridar
|
|
143664-11-3
|
|
TL-895
|
|
1415823-49-2
|
|
BODIPY558/568carboxylicacid
|
BODIPY558/568羧酸
|
150173-72-1
|
|
BODIPY558/568NHSester
|
BODIPY558/568NHS活化酯
|
150173-73-2
|
|
Bradykinin (1-5)
|
|
23815-89-6
|
|
Branebrutinib
|
|
1912445-55-6
|
|
Bradykinin (2-9)
|
|
16875-11-9
|
|
Luxeptinib
|
|
1616428-23-9
|
|
Bosutinib hydrate
|
|
918639-08-4
|
|
TPC2-A1-N
|
|
136186-07-7
|
|
(2R/S)-6-PNG
|
|
68682-01-9
|
|
BODIPYR6Gcarboxylicacid
|
BODIPYR6G羧酸
|
174881-57-3
|
|
(S)-Nicardipine
|
|
76093-36-2
|
|
SAK3
|
|
1256269-87-0
|
|
S116836
|
|
1257628-57-1
|
|
Vecabrutinib
|
|
1510829-06-7
|
|
SR33805
|
|
121345-64-0
|